Design and optimization of new piperidines as renin inhibitors.
Corminboeuf, O., Bezencon, O., Grisostomi, C., Remen, L., Richard-Bildstein, S., Bur, D., Prade, L., Hess, P., Strickner, P., Fischli, W., Steiner, B., Treiber, A.(2010) Bioorg Med Chem Lett 20: 6286-6290
- PubMed: 20843686 
- DOI: https://doi.org/10.1016/j.bmcl.2010.08.086
- Primary Citation of Related Structures:  
3O9L, 3OAD, 3OAG - PubMed Abstract: 
The discovery of a new series of piperidine-based renin inhibitors is described herein. SAR optimization upon the P3 renin sub-pocket is described, leading to the discovery of 9 and 41, two bioavailable renin inhibitors orally active at low doses in a transgenic rat model of hypertension.
Organizational Affiliation: 
Drug Discovery Chemistry & Biochemistry, Actelion Pharmaceuticals Ltd, Gewerbestrasse 16, 4123 Allschwil, Switzerland.